Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication,
belonging to the group of incretin mimetics, approved in April 2005 for the
Jun 15, 2016 ... Exenatide injection may increase the risk that you will develop tumors of the
thyroid gland, including medullary thyroid carcinoma (MTC; a type ...
Following a standardized meal, BYETTA<sup>®</sup> (exenatide) injection reduced elevated
PPG excursions to a nearly flat profile in patients with type 2 diabetes.
BYETTA (exenatide) is a synthetic peptide that was originally identified in the
lizard Heloderma suspectum. Exenatide differs in chemical structure and ...
Easy to read patient leaflet for exenatide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
BYETTA is supplied as 250 mcg/mL exenatide in: • 5 mcg per dose, 60 doses, ...
History of severe hypersensitivity to exenatide or any product components. (4.1).
Dec 19, 2014 ... DRUG CLASS AND MECHANISM: Exenatide is an injectable drug that reduces
the level of sugar (glucose) in the blood. It is used for treating ...
Exenatide is an antidiabetic injection that is used in treating type 2 diabetes.
Read more about diabetes treatments and antidiabetic injections at Patient.
Medscape - Type 2 diabetes-specific dosing for Byetta (exenatide), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
May 4, 2005 ... Dr. Buse: Exenatide is an incretin mimetic. It has structural similarity and binds to
the receptor for GLP-1 and displays a similar broad range of ...